Nalaganje...
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT
CONTEXT: In the Denosumab and High-Dose Teriparatide Administration (DATA-HD) study, we reported that 15 months of combined high-dose (HD) teriparatide and denosumab increased mean areal bone mineral density (aBMD) at the hip and spine more than combined denosumab and standard-dose (SD) teriparatide...
Shranjeno v:
| izdano v: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7112977/ https://ncbi.nlm.nih.gov/pubmed/31674641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgz163 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|